Free Trial

Benitec Biopharma (BNTC) Insider Trading & Ownership

Benitec Biopharma logo
$12.77 +0.19 (+1.51%)
(As of 12/17/2024 ET)

Benitec Biopharma (NASDAQ:BNTC) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.30%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$403,200.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get BNTC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Benitec Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BNTC Insider Buying and Selling by Quarter

Benitec Biopharma Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/3/2024Suvretta Capital Management, LDirectorBuy42,000$9.60$403,200.00  
(Data available from 1/1/2013 forward)

BNTC Insider Trading Activity - Frequently Asked Questions

The list of insiders at Benitec Biopharma includes Suvretta Capital Management, L. Learn more on insiders at BNTC.

1.30% of Benitec Biopharma stock is owned by insiders. Learn more on BNTC's insider holdings.

The following insider purchased BNTC shares in the last 24 months: Suvretta Capital Management, L ($403,200.00).

Insiders have purchased a total of 42,000 BNTC shares in the last 24 months for a total of $403,200.00 bought.

Benitec Biopharma Key Executives

  • Dr. Jerel A. Banks M.D. (Age 49)
    Ph.D., Executive Chairman & CEO
    Compensation: $848.07k
  • Ms. Megan Joan Boston BComm (Age 52)
    CA, Dip., GAICD, Executive Director
    Compensation: $439.17k
  • Dr. Michael Graham
    Head of Discovery & Founding Scientist
  • Dr. Claudia Kloth
    Senior Vice President of Manufacturing


This page (NASDAQ:BNTC) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners